Track market-moving stories before they get noisy

FactSet Research (FDS - Free Report) came out with quarterly earnings of $4.53 per share, beating the Zacks Consensus Estimate of $4.44 per share. This compares to earnings of $4.27 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +2.09%. A quarter ago, it was expected that this financial data firm would post earnings of $4.37 per share when it actually produced earnings of $4.46, delivering a surprise of +2.06%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

FactSet, which belongs to the Zacks Business - Information Services industry, posted revenues of $622.92 million for the quarter ended May 2026, surpassing the Zacks Consensus Estimate by 0.93%. This compares to year-ago revenues of $585.52 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

FactSet shares have lost about 20.7% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for FactSet?While FactSet has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for FactSet was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $4.30 on $626.33 million in revenues for the coming quarter and $17.66 on $2.46 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Business - Information Services is currently in the top 8% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Verisk Analytics (VRSK - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.

This insurance data provider is expected to post quarterly earnings of $1.95 per share in its upcoming report, which represents a year-over-year change of +3.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Verisk Analytics' revenues are expected to be $802.43 million, up 3.9% from the year-ago quarter.

Key Takeaways FDS beat Q3'26 earnings and revenue estimates as organic revenues rose 7% y/y.FactSet saw ASV momentum, with organic ASV up $165M year over year and retention above 95%.FDS reaffirmed FY26 guidance and raised its dividend for the 27th straight year. FactSet Research Systems Inc. (FDS - Free Report) has reported third-quarter fiscal 2026 adjusted earnings of $4.53 per share, beating the Zacks Consensus Estimate of $4.44 by 2%. The figure increased 6.1% from the year-ago quarter.

Revenues of $622.9 million surpassed the consensus mark of $617.2 million by 0.9% and rose 6.4% year over year. Organic revenues grew 7%, while organic ASV rallied 7.1% to $2.49 billion.

FDS’s Revenue Growth Gains TractionFactSet’s top line benefited from continued demand across institutional buy-side and wealth management clients. Organic revenues were $622.9 million, up from $582.2 million in the prior-year period.

The company’s revenue growth reflected stronger client engagement and expanding enterprise relationships. Management noted that clients continued to choose FactSet for differentiated content, analytics and workflow solutions.

FactSet’s ASV Momentum Remains HealthyAnnual Subscription Value, or ASV, was $2.48 billion as of May 31, 2026, compared with $2.34 billion a year ago. Organic ASV came in at $2.49 billion, increasing $165 million year over year.

Organic ASV increased $35.4 million over the past three months. FactSet’s annual ASV retention remained above 95%, while enterprise renewals in the quarter extended 30% in length on average.

FDS’ Regional Revenues Show Broad GrowthRevenues from the Americas were $407.2 million in the third quarter of fiscal 2026, up 7% on an organic basis from the year-ago quarter. The region remained FactSet’s largest revenue contributor, supported by an ASV base of $1.62 billion.

EMEA revenues were $152 million, with organic revenue growth of 5.3%. The Asia Pacific revenues rose 10.5% organically to $63.7 million, whereas organic ASV growth in the region was 10%, the strongest among FactSet’s reported regions.

FactSet’s Margins Reflect Cost PressureAdjusted operating income was $211.8 million, down 1.7% from the prior-year quarter. The adjusted operating margin contracted to 34% from 36.8% a year earlier.

The margin decline reflected higher compensation and technology-related expenses. The GAAP operating margin was 26.7%, down from 33.2% due to higher employee compensation costs, including one-time charges and CEO compensation costs.

FDS’ Cash Flow & Capital Returns ImproveFactSet generated $284.5 million in net cash from operating activities during the quarter, up 12.1% year over year. The free cash flow increased 11.1% to $254 million.

The company returned $243.4 million to shareholders in the quarter. This included $203.1 million in share repurchases and $40.3 million in dividends. FactSet also raised its quarterly dividend by 6 cents to $1.16 per share, marking its 27th consecutive year of dividend increases.

FactSet Reaffirms FY26 OutlookFDS has reaffirmed its fiscal 2026 guidance. The company continues to expect organic ASV growth of $130-$160 million and GAAP revenues of $2.45-$2.47 billion. The mid-point ($2.46 billion) of the guided range meets the Zacks Consensus Estimate.

The adjusted operating margin is expected to be 34-35.5%. Adjusted diluted earnings are projected between $17.25 and $17.75 per share. The mid-point ($17.5) of the guided range is lower than the current consensus estimate of $17.66.

FDS carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Earnings SnapshotPaychex, Inc. (PAYX - Free Report) reported solid fourth-quarter fiscal 2026 results. Adjusted earnings of $1.32 per share surpassed the consensus estimate of $1.31 by a slight margin and increased 11% from the year-ago quarter.

PAYX’s total revenues of $1.61 billion rose 12% year over year and beat the consensus estimate by a slight margin.

Accenture plc (ACN - Free Report) posted third-quarter fiscal 2026 earnings of $3.80 per share, beating the Zacks Consensus Estimate by 2.7%. The metric increased 9% from the year-ago quarter.

ACN’s revenues of $18.718 billion missed the consensus mark by 0.4% but rose 6% year over year in U.S. dollars and 3% in local currency.

Shares of Jack Henry (JKHY - Free Report) have gained 1.3% over the past four weeks to close the last trading session at $137.74, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $177.62 indicates a potential upside of 29%.

The average comprises 13 short-term price targets ranging from a low of $132.00 to a high of $208.00, with a standard deviation of $24.56. While the lowest estimate indicates a decline of 4.2% from the current price level, the most optimistic estimate points to a 51% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

However, an impressive consensus price target is not the only factor that indicates a potential upside in JKHY. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Here's Why There Could be Plenty of Upside Left in JKHYAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The Zacks Consensus Estimate for the current year has increased 0% over the past month, as one estimate has gone higher compared to no negative revision.

Moreover, JKHY currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much JKHY could gain, the direction of price movement it implies does appear to be a good guide.

The first half of the year is over, and it may surprise some investors that European stocks are nearly at parity with U.S. stocks. The tale of the tape as of June 30 tells the story:

The S&P 500 is up about 9.3%. It’s a solid number even if it’s not a record. However, the Euro Stoxx 50 index is up 8.2% this year. This continues a bullish trend in the index that started in October 2022.

There have been several tailwinds for European stocks. These include a weaker dollar relative to the Euro and other European currencies, a valuation re-rating, increased defense spending in the European Union that is flowing into industrials, materials, and defense-adjacent names, broader sector diversification, and a more hawkish interest rate policy.

Get ArcelorMittal alerts:

How to Invest in European StocksIt's fair to say that investors would be cautious about European stocks because the growth isn’t based on fundamental performance. Multiple expansion and currency dynamics aren’t sustainable in the long term.

But the same can be said for the SPDR S&P 500 ETF Trust NYSEARCA: SPY, which is a good proxy for the S&P 500. In fact, "SPY and chill" is a good way to invest as part of a long-term strategy.

For the Euro Stoxx 50 index, the SPDR Euro Stoxx 50 ETF NYSEARCA: FEZ is a nice proxy. However, investors may find they can do better by investing in some of the individual components within the index. Here are three names that have produced index-beating returns in the last 12 months.

ArcelorMittal Rides Europe's Industrial and Steel RevivalThe first stock on this list is headquartered in the Netherlands. AcelorMittal NYSE: MT is one of the world’s largest producers of steel and operates an integrated value chain spanning raw material extraction, steelmaking, processing, and distribution. 

ArcelorMittal Today

MT

ArcelorMittal

$59.23 -0.99 (-1.64%)

As of 11:14 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$30.17▼

$72.50Dividend Yield0.86%

P/E Ratio15.54

Price Target$61.07

Like any steelmaker, AcelorMittal is sensitive to fluctuating steel prices. However, the company has delivered results that highlight its stability in a volatile, competitive market.

MT is up more than 90% in the past 12 months and is trading within 2% of its consensus price target as of June 30. But that growth hasn’t come in a linear fashion. The stock dropped approximately 28% from late February through late March. Since then, the stock was boosted by the company’s Q1 earnings and the announcement of a share buyback program.

A more recent pullback of approximately 17% from its 52-week high leaves room for investors to get involved with a company that’s expected to grow earnings over 49% in the next 12 months. Investors will find out more when the company reports Q2 2026 earnings, scheduled for July 30.

Arm Holdings Remains a Core AI Infrastructure Growth StockARM Holdings NYSE: ARM is one of the leading names in the AI infrastructure space. The England-based semiconductor IP company doesn’t manufacture chips. Rather, it licenses its architecture and instruction set to other companies, who then design and produce their own chips based on Arm's technology.

ARM Today

$338.21 -16.36 (-4.61%)

As of 11:14 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$100.02▼

$452.70P/E Ratio401.86

Price Target$279.83

Like all the names in this space, ARM has been subject to volatile price swings. The stock is up over 220% in 2026, but has been subject to two drops of nearly 25% from June 4 through June 30.

Much of that is due to the general volatility in the chip sector, which could continue. However, analysts still predict earnings growth of approximately 77% in the next 12 months. That’s likely to be the catalyst that drives further gains. It may also be enough for investors to continue overlooking the stock’s lofty valuation of over 300x forward earnings.

Investors should expect more volatility as the AI infrastructure trade continues to shake out. But as long as chip demand remains elevated, ARM remains an essential name for investors looking to find profits.

Novartis Offers Defensive Growth Through Innovation and DividendsNovartis Today

$153.96 -2.76 (-1.76%)

As of 11:14 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$112.34▼

$170.46Dividend Yield2.00%

P/E Ratio22.08

Price Target$141.20

Biopharma stocks may offer significant upside for the rest of 2026 and beyond. Among European stocks, Novartis NYSE: NVS is a name to watch. The company is based in Switzerland and has a prolific catalog of currently available products as well as a deep pipeline in areas such as oncology and gene therapy.

The company also faces threats from biosimilar (generic) products and its own research & development (R&D) spending, which is significant. Despite that spending, the company still expects to have earnings growth of around 11% in the next 12 months.

NVS is up about 14% in 2026 and is about 8% below its consensus price target of $141.20. The long-term story will require new revenue streams to offset its R&D spend, but it may not be time to fade the stock just yet.

Should You Invest $1,000 in ArcelorMittal Right Now?Before you consider ArcelorMittal, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ArcelorMittal wasn't on the list.

While ArcelorMittal currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Ralph Lauren (RL - Free Report) Ralph Lauren Corp. is a major designer, marketer and distributor of premium lifestyle products in North America, Europe, Asia, and internationally. It offers products in the apparel, footwear, accessories, home furnishings, and other licensed product categories. The company possesses a strong portfolio of globally recognized brand names such as Polo Ralph Lauren, Ralph Lauren Purple Label, Ralph Lauren Collection, Double RL, Lauren Ralph Lauren, Polo Golf Ralph Lauren, Ralph Lauren Golf, RLX Ralph Lauren, Polo Ralph Lauren Children, Chaps, Club Monaco and American Living.

RL is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.

Momentum investors should take note of this Consumer Discretionary stock. RL has a Momentum Style Score of B, and shares are up 10.4% over the past four weeks.

For fiscal 2027, six analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.28 to $18.33 per share. RL boasts an average earnings surprise of +9.1%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, RL should be on investors' short list.

Mark T. Walsh, CEO & Director of Savers Value Village (SVV +0.10%), reported the sale of common stock on June 18, 2026, amid ongoing portfolio adjustments and sector headwinds, according to a SEC Form 4 filing.

Transaction summaryMetricValueContextShares sold (direct)41,600Direct open-market shares sold by CEO on June 18, 2026Transaction value$419,000Approximate total value based on weighted average price of $10.08 per sharePost-transaction shares (direct)47,363Directly held shares by Walsh after the transactionPost-transaction value (direct ownership)~$481,000Estimated value based on June 18, 2026 market close ($10.15)Transaction value based on SEC Form 4 weighted average purchase price ($10.08); post-transaction value based on June 18, 2026 market close ($10.15).

Key questionsHow material is this transaction relative to Mark T. Walsh's prior trading activity?
The 41,600 shares sold constituted the largest single direct sale by Walsh to date, representing nearly half of his direct stake and exceeding the mean size of prior sell-only transactions (~22,500 shares).What is the impact on Walsh's ongoing ownership and influence at the company?
Following this sale, Walsh's direct holdings fell to 47,363 shares, or approximately 0.03% of outstanding shares, suggesting a diminishing direct equity interest though he remains CEO & Director.Was this transaction linked to a pre-arranged trading plan?
Yes, the filing discloses the sale was executed under a 10b5-1 plan adopted on March 17, 2026, indicating the transaction was scheduled in advance as part of routine liquidity planning.How does the timing relate to share price trends and capacity constraints?
The sale was executed with shares priced at $10.08 (weighted average), amidst a one-year total return of -2.03% as of the trade date; the declining size of recent trades reflects the limited remaining shares available following a consistent reduction in holdings since 2024.Company overviewMetricValueRevenue (TTM)$1.7 billionNet income (TTM)$22.1 millionEmployees22,700Price (as of market close June 18, 2026)$10.15* 1-year performance is calculated using June 18, 2026 as the reference date.

Company snapshotOffers pre-owned merchandise including apparel, footwear, accessories, housewares, and books through retail stores operating under banners such as Savers, Value Village, Village des Valeurs, Unique, and 2nd Avenue.Generates revenue by sourcing goods from non-profit partners, processing and merchandising these items, and selling them to retail and wholesale customers.Targets value-conscious consumers seeking affordable second-hand goods across the United States, Canada, and Australia.Savers Value Village is a leading operator in the specialty retail sector, focusing on the sale of second-hand merchandise through a network of stores across North America and Australia. The company leverages partnerships with non-profit organizations to source inventory, enabling a scalable and cost-effective supply chain strategy. Its differentiated model emphasizes sustainability and value, appealing to a broad customer base seeking affordable alternatives to new retail goods.

What this transaction means for investorsAlthough Form 4 filings do not discuss why an insider chooses to sell, it is difficult to put a positive spin on a CEO selling just under half of his holdings in the company’s stock.

However, the fact that this reduces his holdings to just 0.03% of outstanding shares indicates he has no significant stake in the company. Since becoming CEO in October 2019, the stock has lost approximately 55% of its value.

However, the financials are not wholly negative. In the first quarter of 2026, revenue of $403 million rose 9% yearly. This came after a similar 9% net sales increase for 2025. Also, the company turned an operating profit, negated only by interest expenses and a foreign currency loss.

Moreover, the stock has risen since the beginning of the year. Also, while its P/E ratio is at 77, analysts estimate its forward P/E ratio at 22, well below the S&P 500 average of 32.

Today's Change

(

0.10

%) $

0.01

Current Price

$

10.10

Such metrics indicate the consumer discretionary stock is a hold or arguably even a buy, which makes it more likely Walsh sold the stock for reasons not related to the company’s performance.

Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Savers Value Village. The Motley Fool has a disclosure policy.

Hims & Hers Health, Inc. (HIMS - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this company have returned +26% over the past month versus the Zacks S&P 500 composite's -1.8% change. The Zacks Medical Info Systems industry, to which Hims & Hers Health belongs, has gained 11.8% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Hims & Hers Health is expected to post a loss of $0.06 per share for the current quarter, representing a year-over-year change of -135.3%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of -$0.23 points to a change of -143.4% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $0.5 indicates a change of +320.9% from what Hims & Hers Health is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Hims & Hers Health is rated Zacks Rank #5 (Strong Sell).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Hims & Hers Health, the consensus sales estimate of $689.49 million for the current quarter points to a year-over-year change of +26.6%. The $2.9 billion and $3.4 billion estimates for the current and next fiscal years indicate changes of +23.7% and +17.2%, respectively.

Last Reported Results and Surprise HistoryHims & Hers Health reported revenues of $608.1 million in the last reported quarter, representing a year-over-year change of +3.8%. EPS of -$0.18 for the same period compares with $0.2 a year ago.

Compared to the Zacks Consensus Estimate of $619.62 million, the reported revenues represent a surprise of -1.86%. The EPS surprise was -550%.

Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates just once over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Hims & Hers Health is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Hims & Hers Health. However, its Zacks Rank #5 does suggest that it may underperform the broader market in the near term.

Geron Corporation delivered Q1'26 Rytelo revenues of $51.8M, up 8% sequentially, with two consecutive quarters of demand growth. GERN maintained 2026 guidance, with net product revenues of $220M-$240M expected. Management is now prioritizing high-volume community accounts, aiming to shift sales mix from academic centers to the broader 80% community-driven market.

The Oils-Energy group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Imperial Oil (IMO - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Oils-Energy sector should help us answer this question.

Imperial Oil is a member of our Oils-Energy group, which includes 252 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Imperial Oil is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for IMO's full-year earnings has moved 59.4% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, IMO has moved about 29.8% on a year-to-date basis. Meanwhile, stocks in the Oils-Energy group have gained about 18.6% on average. This shows that Imperial Oil is outperforming its peers so far this year.

One other Oils-Energy stock that has outperformed the sector so far this year is Cenovus Energy (CVE - Free Report) . The stock is up 46.6% year-to-date.

In Cenovus Energy's case, the consensus EPS estimate for the current year increased 75.6% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Imperial Oil belongs to the Oil and Gas - Integrated - Canadian industry, a group that includes 4 individual stocks and currently sits at #26 in the Zacks Industry Rank. On average, this group has gained an average of 30.6% so far this year, meaning that IMO is slightly underperforming its industry in terms of year-to-date returns. Cenovus Energy is also part of the same industry.

Investors interested in the Oils-Energy sector may want to keep a close eye on Imperial Oil and Cenovus Energy as they attempt to continue their solid performance.

GE Vernova (GEV - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the past month, shares of this the energy business spun off from General Electric have returned +21.2%, compared to the Zacks S&P 500 composite's -1.8% change. During this period, the Zacks Alternative Energy - Other industry, which GE Vernova falls in, has gained 3.6%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, GE Vernova is expected to post earnings of $3.16 per share, indicating a change of +69.9% from the year-ago quarter. The Zacks Consensus Estimate has changed +2.1% over the last 30 days.

The consensus earnings estimate of $30.59 for the current fiscal year indicates a year-over-year change of +72.9%. This estimate has changed +1.1% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $24.38 indicates a change of -20.3% from what GE Vernova is expected to report a year ago. Over the past month, the estimate has changed +0.1%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, GE Vernova is rated Zacks Rank #2 (Buy).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For GE Vernova, the consensus sales estimate for the current quarter of $10.78 billion indicates a year-over-year change of +18.3%. For the current and next fiscal years, $45.34 billion and $51.82 billion estimates indicate +19.1% and +14.3% changes, respectively.

Last Reported Results and Surprise HistoryGE Vernova reported revenues of $9.34 billion in the last reported quarter, representing a year-over-year change of +16.3%. EPS of $1.98 for the same period compares with $0.91 a year ago.

Compared to the Zacks Consensus Estimate of $9.3 billion, the reported revenues represent a surprise of +0.47%. The EPS surprise was +7.61%.

Over the last four quarters, GE Vernova surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

GE Vernova is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about GE Vernova. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.

Here’s what investors need to know.

CoreWeave stock is among today’s weakest performers. Why is CRWV stock falling? According to Bloomberg, Meta’s internal "Meta Compute" initiative could include selling access to AI models hosted on Meta infrastructure as well as raw computing capacity, a model described as similar to neocloud companies like CoreWeave. Meta’s plans remain in development and could change, and a company spokesperson declined to comment.

The report is a direct overhang for CoreWeave because the company’s business is built around selling high-performance GPU cloud capacity for AI workloads. CoreWeave operates as an AI infrastructure provider, offering cloud access to GPU clusters and data centers designed to support demanding AI workloads.

Meta Could Pressure AI Compute PricingInvestors may be selling CRWV on fears that Meta could become a powerful competitor in the same market. Unlike smaller AI cloud providers, Meta already owns massive data-center infrastructure, AI chips, models and developer relationships. If Meta begins renting unused compute, it could increase supply, pressure GPU rental pricing and weaken CoreWeave’s scarcity premium.

That matters because CoreWeave trades as a high-growth AI infrastructure play. Any sign that hyperscalers may flood the market with competing compute could compress CRWV’s multiple, even if AI demand remains strong.

CoreWeave Technical Levels To WatchFrom a trend perspective, CRWV is still in a repair phase: it’s trading 13.4% below its 20-day SMA and 18.2% below its 50-day SMA, which tells you recent rallies have struggled to stick. It’s also 9.9% below the 100-day SMA and 10.9% below the 200-day SMA, keeping the longer-term posture tilted defensive even after the earlier golden cross in May.

MACD is the cleaner momentum read right now, and it’s below its signal line with a negative histogram, which points to upside pressure fading versus the prior upswing. In plain term, MACD vs. the signal line helps gauge whether momentum is building or cooling, and this setup says buyers still need to prove they can regain control.

The 20-day SMA sitting below the 50-day SMA adds to the near-term bearish structure, even though the 50-day SMA remains above the 200-day SMA (the golden cross from May). Zooming out, the stock is still down 42.60% over the past 12 months, so bulls generally want to see a base form before expecting a sustained trend reversal.

Key Resistance: $91.00 — a nearby round-number area where rebounds can stall before the stock can work back toward its short-term moving averages Key Support: $87.00 — a nearby pivot zone where buyers may try to defend the recent range and prevent a deeper slide toward the lower end of the 52-week band What Is CoreWeave and Its Business Model?CoreWeave is a modern cloud infrastructure company that offers Nvidia GPUs and other essential AI hardware with optimized efficiency to handle the most demanding AI training and inference workloads. Its cloud platform supports the development and use of foundational large language models and the delivery of next-generation AI applications to satisfy the growing demand for AI around the world.

In practice, that puts the company in the middle of the AI compute buildout, where customers care about access to high-end GPUs, uptime, and the ability to scale quickly. For the stock, that means sentiment can swing hard with changes in AI spending expectations and broader risk appetite for high-growth infrastructure plays.

CoreWeave Stock Price Activity TodayCRWV Stock Price Activity: CoreWeave shares were trading lower by 10.55% to $89.04 at the time of publication on Wednesday, according to Benzinga Pro data.

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Key Takeaways Shutterstock and Getty decided to abandon their $3.7 billion merger after hitting regulatory roadblocks. Getty said Tuesday that a U.K. regulator would have required it to sell Shutterstock's editorial division to get the deal approved, a step Getty's board was not willing to take. Get personalized, AI-powered answers built on 27+ years of trusted expertise.

Getty Images and Shutterstock are calling off their $3.7 billion merger after hitting regulatory roadblocks. Investors aren't cheering the news.

In a Tuesday regulatory filing, Getty (GETY) that the U.K.'s Competition and Markets Authority determined the new Getty would be required to sell off Shutterstock's (SSTK) editorial business to get the deal approved. Getty said its board decided not to sell the division and will abandon its merger plans.1

Shutterstock shares plummeted 32% in premarket trading to $9.40 following the news, which would be their lowest level since their 2012 debut. Getty shares were down about 4% to 83 cents.

Why This Matters to Investors Wednesday's tumble suggests investors are disappointed by the move and less confident in the companies individually than they were about the combined firm.

The companies first announced the deal in January 2025, calling the transaction a merger of equals that would see Shutterstock shareholders get the option to receive cash, shares of the new Getty, or a combination of the two. At the time, the companies said the deal would allow the combined company to invest more in new offerings like 3D imagery and generative AI tools. The U.S. Department of Justice cleared the deal to proceed back in February.2

Since the day the deal was announced, both Getty and Shutterstock shares have lost nearly 70% of their value amid worries that the spread of AI image creation tools could reduce demand for stock photos in the long term. Getty also said Tuesday it will retain a financial advisor to advise the company on "strategic financing alternatives" the company could pursue since the deal has been dropped.

Getty declined to comment on the board's decision, and Shutterstock did not respond to a request for comment in time for publication.

Eldorado Gold is rated Buy, driven by the near-completion of its transformational Skouries copper-gold project in Greece. Skouries will diversify EGO's product mix, enhance cash flow, and reduce single-commodity dependency, with commercial production targeted for Q4 2026. EGO's robust balance sheet, existing mine cash flows, and non-recourse project financing significantly mitigate execution and financial risks.

Bitmine, Sharplink and Joe Lubin fund a new dedicated go-to-market organization built by Ethereum Foundation alumni

, /PRNewswire/ -- Ethereum Institutional, an independent non-profit organization, today announced its public launch as the dedicated institutional front door for the Ethereum ecosystem. The organization consolidates a year of institutional engagement work led by the Ethereum Foundation's go-to-market team, housing it in an independent organization with a sharper mission, broader geographic footprint and long-term funding. Bitmine Immersion Technologies, Inc. (NYSE: BMNR), Sharplink, Inc. (NASDAQ: SBET) and Ethereum co-founder Joe Lubin are anchoring the funding, along with dozens of individual and institutional contributors.

Ethereum Institutional Ethereum Institutional exists so as the world's largest financial institutions make their foundational, long-lived platform decisions about tokenization, stablecoins and onchain market infrastructure, they engage Ethereum through a credible, neutral counterpart. Ethereum does not force a single rigid configuration, but lets institutions choose the approach that fits each use case, while deriving security from the world's most robust and reliable digital asset settlement layer.

This launch represents the second major independent steward organization for Ethereum's ecosystem unveiled in the last week, following the announcement of Ethlabs, a research and development lab also founded by former Ethereum Foundation leaders. Together, Ethlabs and Ethereum Institutional form complementary pillars of Ethereum's next chapter: one advancing protocol-layer innovation and core infrastructure, the other ensuring institutions have a credible, dedicated counterpart to guide them from evaluation through deployment at scale. Ethereum Institutional brings ecosystem experience and unbiased expertise to the world's largest financial institutions.

The institutional adoption moment is now. Ethereum currently hosts roughly $180 billion of stablecoins on mainnet, approximately 60% of total stablecoin supply and roughly two-thirds of all tokenized real-world assets. Leading financial institutions across asset management, banking, payments, custody and market infrastructure are actively building on the network. Meanwhile, competing ecosystems have made institutional adoption their explicit commercial priority, each running well-funded business development organizations with dedicated mandates to land institutional deployments.

The platform decisions institutions are making in the next 12-24 months will set the topology of onchain finance for decades. Coordinated, credible representation now unifies the conversation, and supports expanding Ethereum's robust network, which benefits its existing and future users.

Ethereum Institutional launches with a proven track record and existing momentum: the team has built over 500 institutional relationships covering the global universe of Tier-1 banks, top-tier asset managers, sovereign institutions, custodians and market infrastructure providers. The team has established a thought leader gathering through the Institutional Ethereum Forum, which brought together more than 150 senior executives and Heads of Digital Assets from institutions representing roughly $250 trillion in combined assets under management.

Ethereum Institutional will operate along five focus areas from day one: Institutional Education and Engagement, Institutional Intelligence, ETH and Ecosystem Marketing, Standards and Best Practices and Institutional Events. Geographic coverage will expand from New York, London, Hong Kong, and Singapore into additional primary financial centers including Zurich, Frankfurt, Tokyo and Abu Dhabi, with dedicated institutional leads embedded in each region operating under a shared credibly neutral mandate.

Thomas "Tom" Lee, Chairman of Bitmine. "Financial institutions are making infrastructure decisions today that will shape capital markets for decades, and Ethereum is increasingly at the center of those conversations. Ethereum Institutional arrives at exactly the right moment, creating a trusted, independent home where institutions can engage with the ecosystem, develop standards and accelerate adoption. It's an important step toward making Ethereum the backbone of the next generation of global financial infrastructure."

Joseph Chalom, Chief Executive Officer of Sharplink. "I spent two decades helping the world's largest institutions adopt new technology, and I have rarely seen the conditions align the way they have for Ethereum. These institutions are moving from interest to action across tokenization, stablecoins and a new financial market infrastructure. Ethereum Institutional was built to meet them at exactly this moment."

Joe Lubin, Ethereum co-founder and Chief Executive Officer of Consensys. "Ethereum has become the premier infrastructure for decentralized, verifiable, programmable trust. For more than a decade, the researchers, developers and ecosystem have focused on doing the hard work without cutting corners: making the network more scalable, more affordable, more usable, and protecting credible neutrality and censorship resistance via progressive rigorous decentralization. This is why it has been the first and prevailing choice for the majority of stablecoin activity, tokenized assets, DeFi and other onchain financial infrastructure. Traditional finance is already onboarding itself to Ethereum's decentralized rails. Ethereum Institutional will help accelerate this next major chapter, enabling institutions to engage at scale, promoting the openness and permissionless innovation that make the network uniquely powerful and valuable."

Concluding, David Walsh, Executive Director of Ethereum Institutional, said, "Ethereum's credible neutrality is one of its greatest strengths, but neutrality without representation can often be seen as silence. The Ethereum ecosystem needs a credible, independent counterpart institutions can engage with directly; someone financial leaders can call, brief their board with, and trust to come back with honest answers. Ethereum Institutional exists to be this dedicated counterpart. Our job is to translate institutional requirements into deployments that scale, and ultimately to make Ethereum the foundational layer for institutional finance."

Lee, Chalom and Walsh will serve as the members of the Board of Directors.

About Bitmine 
Bitmine (NYSE: BMNR) is a Bitcoin miner with operations in the US. The company is deploying its excess capital to be the leading Ethereum Treasury company in the world, implementing an innovative digital asset strategy for institutional investors and public market participants. Guided by its philosophy of "the alchemy of 5%," the Company is committed to ETH as its primary treasury reserve asset, leveraging native protocol-level activities including staking and decentralized finance mechanisms. The Company launched MAVAN (Made-in America Validator Network), a dedicated staking infrastructure for Bitmine assets, in 2026.

About Sharplink

Sharplink (NASDAQ: SBET) is a leading institutional-grade Ethereum treasury platform designed to give public market investors smarter, more productive exposure to ETH. Ethereum underpins the majority of global stablecoin, tokenized real-world assets and decentralized finance settlement. Sharplink was founded in 2019 and is headquartered in Miami, Florida. Learn more at sharplink.com.

About Ethereum Institutional

Ethereum Institutional is an independent, non-profit organization dedicated to the institutional adoption of Ethereum. The organization functions as the neutral front door for institutions to enter the Ethereum ecosystem, working directly with banks, asset managers, custodians, market infrastructures, fintechs, and sovereign institutions to translate their requirements into on-chain deployments. The organization operates five focus areas: Institutional Education and Engagement, Institutional Intelligence, ETH and Ecosystem Marketing, Industry Discovery and Requirements, and Institutional Events. Learn more at ethereuminstitutional.org.

Forward-Looking Statement

This press release contains statements regarding anticipated institutional interest in Ethereum, research focus and roadmaps, governance arrangements, funding availability, and program scaling. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including market conditions for digital assets, regulatory changes, protocol-level developments, timing of institutional deployments, funding availability and general economic conditions. Forward-looking statements speak only as of the date of this release and are not guarantees. Ethereum Institutional and its funders undertake no obligation to update them except as required by law. This press release is for informational purposes only.

SOURCE Bitmine Immersion Technologies, Inc.

London, July 01, 2026 (GLOBE NEWSWIRE) -- Flexjet and Formula 1® today announce a multi-year partnership, bringing together two leading global brands at the pinnacle of luxury private aviation and motor racing, and naming Flexjet as the Official Private Aviation Supplier of Formula 1®.

Defined by a commitment to performance, precision and extraordinary experiences, the exclusive partnership officially launches ahead of this weekend’s FORMULA 1 PIRELLI BRITISH GRAND PRIX 2026 at Silverstone, where luxury private aviation leader Flexjet - which operates a global fleet of over 340 ultramodern private jets including one of the world’s largest and most refined collection of large cabin aircraft - will elevate the private aviation experience within the sport.

Continuing across the global F1® calendar, the collaboration will showcase Flexjet’s effortless and efficient international connectivity via fleet access for VIPs, executives and teams. In addition to Flexjet’s inclusive sustainability programme, flights will be operated using Sustainable Aviation Fuel (SAF).

“This is a natural alignment of two worlds in which both luxury aircraft and fast cars require absolute precision and flawless coordination to achieve success,” said Kenn Ricci, Chairman of Flexjet. “As we look to the future alongside our partners at LVMH, cementing our longstanding ties with the world of motor racing allows us to deliver unparalleled, ultra-luxury experiences, both on the ground and in the air.”

Through the global partnership, Flexjet will leverage Formula 1®’s prodigious worldwide reach and elite audience appeal. Flexjet’s fractional aircraft Owners will also enjoy exceptional hospitality and behind-the-scenes experiences at selected global Grand Prix™ race events – as part of the Flexjet Red Label® programme providing curated experiences inside and outside of the cabin.

Flexjet and Formula 1® will furthermore collaborate on a digital content series which celebrates their powerful synergies and shared vision.

Stefano Domenicali, President and CEO of Formula 1® said: “As a global championship we are constantly on the move, engaging with our fans, partners, promoters, and stakeholders all around the world, 365 days a year. Having partners that support us on our mission to deliver the best sport, and an unforgettable show is vital to our ongoing success, so I am delighted to welcome Flexjet as a new Official Supplier. We share a deep passion and commitment to precision and innovation, and a dedication to providing exceptional experiences.”

Download video & high resolution images

About Flexjet

Flexjet, a global leader in private aviation, first entered the fractional jet ownership market in 1995. Flexjet offers fractional jet ownership and leasing and is the first in the world to be recognised as achieving the Air Charter Safety Foundation’s Industry Audit Standard, is the first and only company to be honoured with 26 FAA Diamond Awards for Excellence, upholds an ARG/US Platinum Safety Rating, a 4AIR Bronze Sustainable Rating and is certified at Stage 3 with IS-BAO. Flexjet Technical Services, a fully integrated maintenance and product support infrastructure, has operations in the U.S., Canada and Europe and its primary mission is to support the maintenance of the Flexjet fleet. Red Label by Flexjet, a market differentiator, features an ultra-modern fleet, flight crews assigned to a single aircraft and the LXi Cabin Collection of interiors. The global fleet includes the Embraer Phenom 300, Praetor 500 and 600, Bombardier Challenger 350/3500 and the Gulfstream G450, G500, G650 and G700. Flexjet’s helicopter division, which serves the northeastern United States, Florida and the United Kingdom, offers leases, helicopter cards and interchange access for its aircraft Owners. Flexjet owns, operates and maintains its Sikorsky S-76 helicopters, which boast 55,000 hours of safe flying certified by Wyvern and ARG/US. For more details, visit www.flexjet.com or follow us on Instagram @Flexjetllc.

About Formula 1®

Formula 1® racing began in 1950 and is the world’s most prestigious motor racing competition, as well as the world’s most popular annual sporting series. Formula One World Championship Limited is part of Formula 1® and holds the exclusive commercial rights to the FIA Formula One World Championship™. Formula 1® is a subsidiary of Liberty Media Corporation (NASDAQ: FWONA, FWONK, LLYVA, LLVYK) attributed to the Formula One Group tracking stock. The F1 logo, F1 FORMULA 1 logo, FORMULA 1, F1, FIA FORMULA ONE WORLD CHAMPIONSHIP, GRAND PRIX, PADDOCK CLUB and related marks are trademarks of Formula One Licensing BV, a Formula 1 company. All rights reserved.

Contact:
Susan Ruiz Patton
Flexjet Senior Director of External Communications
216-333-9526 (mobile)
[email protected]

FORMULA 1® AND FLEXJET ANNOUNCE MULTI-YEAR GLOBAL PARTNERSHIP

FORMULA 1® AND FLEXJET ANNOUNCE MULTI-YEAR GLOBAL PARTNERSHIP Flexjet and Formula 1® have announced a multi-year partnership, bringing together two leading global...

Modine (MOD - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this heating and cooling products maker have returned -13% over the past month versus the Zacks S&P 500 composite's -1.8% change. The Zacks Automotive - Original Equipment industry, to which Modine belongs, has gained 1.1% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Modine is expected to post earnings of $1.43 per share for the current quarter, representing a year-over-year change of +34.9%. Over the last 30 days, the Zacks Consensus Estimate has changed -2.2%.

For the current fiscal year, the consensus earnings estimate of $7.73 points to a change of +54% from the prior year. Over the last 30 days, this estimate has changed +1.7%.

For the next fiscal year, the consensus earnings estimate of $10.86 indicates a change of +40.5% from what Modine is expected to report a year ago. Over the past month, the estimate has changed +0.3%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Modine is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Modine, the consensus sales estimate for the current quarter of $895.49 million indicates a year-over-year change of +31.2%. For the current and next fiscal years, $4.03 billion and $4.76 billion estimates indicate +26.8% and +18% changes, respectively.

Last Reported Results and Surprise HistoryModine reported revenues of $954.4 million in the last reported quarter, representing a year-over-year change of +47.5%. EPS of $1.71 for the same period compares with $1.12 a year ago.

Compared to the Zacks Consensus Estimate of $907.34 million, the reported revenues represent a surprise of +5.19%. The EPS surprise was +13.25%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Modine is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Modine. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Space Exploration Technologies (SPCX 3.21%) made its public debut this month, and demand was so intense that the stock quickly shot up to $225 per share from its original $135 initial public offering (IPO) price. The hype has since died down, and SpaceX is currently trading near $150 as of this writing. So how do investors decide whether to buy, hold, or sell in light of this pullback?

First, we must consider the price dip itself and whether it is truly an opportunity, a warning, or just short-term noise to ignore. There really isn't much analyst consensus on SpaceX. Price targets range from an absurdly high $310 to $62 per share, so different conclusions can be reached from the outset.

Only time will tell who has the correct take on Elon Musk's multi-trillion-dollar business. However, this dip is likely driven by a combination of fears and concerns about SpaceX's debt load, inflated valuation, and ability to grow revenue to justify that sky-high valuation.

Image source: The Motley Fool.

SpaceX announced it would issue $25 billion in bonds this week, following its record-breaking $85 billion IPO raise. The additional debt has some investors concerned. Lastly, insider lockups will expire in the coming months, which could trigger a selling spree that pushes the stock lower. With all that said, this dip is generally reactionary and not necessarily tied to SpaceX's financials. The company hasn't even released its first quarterly earnings report.

Today's Change

(

-3.21

%) $

-5.48

Current Price

$

165.38

Should you buy? While SpaceX's price is still inflated, there's a bull case to consider: the businesses it owns and their growth trajectory. The subsidiary Starlink, a satellite Internet network, is globally scalable and already generates recurring revenue. SpaceX also owns xAI, which lags competitors, but could catch up over time and eventually become profitable. SpaceX, of course, currently dominates the medium-lift reusable rocket market.

There's a lot of potential revenue in a diversified portfolio. Success stories like Amazon, which is both an e-commerce platform and a leading cloud provider, show what is possible with successful execution and a long enough time horizon.

Should you hold? If you already hold SpaceX shares, the stock will be volatile for the foreseeable future, and trying to time the market isn't a winning strategy in the long run. It's going to take years for revenue to catch up with valuation. Right now, SpaceX trades at more than 100 times its sales. Holding the stock will require the stomach to handle price swings.

The stock has been trading for less than a month, so holding is a reasonable option because investors haven't given the company nearly enough time to find its footing.

Should you sell? If you bought SpaceX and the stock has become too concentrated in your portfolio, or you find yourself unable to handle the volatile price swings, you may want to consider reducing your position. Or perhaps you've become bearish on the space industry and on SpaceX's ability to become a profitable, cash-flowing machine. In that case, selling makes sense.

There isn't one right answer when it comes to buying, holding, or selling any stock. In general, it's best to buy and hold for a minimum of five years to give stocks a chance to grow and weather any market downturns. In the case of SpaceX, investors need patience, a high risk tolerance, and the ability to wait for revenue to catch up with the more than $2 trillion valuation.

That may not happen for several years. Your personal portfolio goals are what matter most.

Shares of Apple Inc NASDAQ: AAPL are trading around $285 this week, down almost 10% from the all-time highs they hit earlier this month. A string of unhelpful headlines has weighed on sentiment, from the underwhelming Siri AI reveal at WWDC to last week's price hikes on MacBooks and iPads.

Apple Today

$292.98 +3.62 (+1.25%)

As of 10:28 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$201.50▼

$317.40Dividend Yield0.37%

P/E Ratio35.36

Price Target$314.85

The latest update is more interesting than the market has so far given it credit for. It was reported last week that Apple has launched a lobbying campaign to secure clearance from the U.S. administration to procure memory chips from CXMT, a Chinese company currently on the Pentagon's 1260H list. For context, that's the U.S. government's official register of businesses operating in the country that are believed to have ties to the Chinese military.

Get Apple alerts:

While the headline reads as another piece of complicated news for a stock that's had plenty of it, the underlying signal is potentially more constructive.

Apple is clearly moving with speed to address the cost pressure that's been weighing on it, even if the path is far from straightforward.

Why Apple Is Lobbying for Chinese MemoryThe overall context here is important. Memory chip prices have been surging globally, driven by the same AI-related demand that's been powering rallies in stocks across the board. For Apple, the impact is direct, with CEO Tim Cook publicly admitting last week that the cost pressure had become "unsustainable" and that "price increases are unavoidable." That admission was followed swiftly by price hikes across many of its core products, including its MacBook and iPad ranges, and the stock had its worst day in over a year as a result.

The lobbying campaign now reported is an attempt to ease that exact pressure. CXMT is one of the largest memory chipmakers in China, and securing access to its output could go a long way to offset some of the supply-side bottleneck Apple is facing.

The complication is that CXMT was added to the Pentagon's 1260H list this month, due to its alleged links to the Chinese military. While Apple isn’t explicitly barred from buying from these firms, dealing with companies on that list carries reputational risks and has the whiff of desperation about it.

What Wedbush Is SayingFrom that viewpoint, it’s understandable that Wedbush has cautioned that any benefit from this lobbying effort may be limited, at least in the short term. Apple tried something similar with a Chinese competitor of CXMT, YMTC, back in 2022 and faced significant pushback from Congress. There's every chance the same resistance could repeat itself this time around.

The bigger problem, according to Wedbush, is that the underlying issue isn't really about access. It's about capacity. As they pointed out in a note to clients on the news, "there is simply not enough production capability to support current memory demand."

In other words, even if Apple succeeds in unlocking access to CXMT's output, it won’t fundamentally change the tightening supply-and-demand dynamic that's been driving prices higher. That's a fair caution, and it's worth weighing carefully before getting carried away with the bullish framing.

Why the Market May Still Be Missing the Bigger PictureThat said, focusing purely on the near-term economics may be missing the more important strategic signal. Apple is one of the most capable supply chain operators on earth, and the fact that it's actively lobbying the administration to expand its options speaks to a company that isn't simply sitting back and absorbing this cost squeeze. It's moving aggressively on multiple fronts to find a way through.

This needs to be viewed in the broader context of the strategic moves Apple has been making in recent weeks. The partnership with Intel Corp NASDAQ: INTC on domestic chip production, the deeper push into U.S. manufacturing, and now the lobbying effort on Chinese memory all point to the same underlying story.

Apple is acting to diversify its supply chain in every direction it can, and strategic agility has historically been one of its biggest competitive advantages. For investors, the path to success from this China play may not be smooth, but the direction of travel is reassuring.

A Stock Setup That's Becoming Hard to IgnoreThe combination of all this with Apple's recent pullback makes the current setup interesting. The stock is now meaningfully cheaper than it was at the start of the month. Still, the long-term story, anchored by AI agentic potential, ecosystem stickiness, and a deepening Services revenue mix, hasn't actually changed.

Apple Inc. (AAPL) Price Chart for Wednesday, July, 1, 2026

For investors looking through the noise and asking whether Apple’s trajectory is meaningfully different today than it was a few weeks ago, the answer is, increasingly, that it isn't. The recent headlines might be telling investors to be careful, but the underlying picture is quietly telling them something rather different.

Should You Invest $1,000 in Apple Right Now?Before you consider Apple, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apple wasn't on the list.

While Apple currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

A pause in talks between the U.S. and Iran have futures taking a step back ahead of Wednesday's opening bell. Tom White turns to the trading action and explains how persisting headwinds keep markets pressured.

Meta Platforms stock is showing upward momentum. What’s ahead for META stock? According to Bloomberg, Meta is forming a business to generate revenue from excess computing power sold to outside customers as part of an internal initiative called Meta Compute.

The plans include two potential offerings. The first involves selling access to various AI models hosted on Meta’s existing infrastructure—similar to Amazon Web Services’ Bedrock offering—with Meta running the data centers and chips powering the models, including its own Muse Spark models, and charging developers to access them. The second involves selling access to raw computing capacity, similar to neocloud businesses like CoreWeave.

Meta Compute is led by Santosh Janardhan, Meta’s head of infrastructure; Daniel Gross, a leader inside the Meta Superintelligence Labs AI unit; and Meta President Dina Powell McCormick.

Bloomberg noted that the company’s plans are still in development and could change. Meta did not immediately respond to Benzinga’s request for comment.

Meta Shares Trend HigherMETA Price Action: At the time of publication, Meta shares are trading 7.05% higher at $603.00, according to data from Benzinga Pro.

Image via Shutterstock

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Alex Coffey says the second half of 2026 has a strong foundation underneath when turning to historical market metrics. One corner of Wall Street not seeing significant strength: hyperscalers, which have lagged compared to chipmaking peers.

Meta has spent billions of dollars developing AI and building out data centers to support it. But now, the company may be preparing to put those data centers to a more immediately profitable purpose.

On Wednesday, Bloomberg reported that Meta is developing plans for a cloud infrastructure business, selling access to both AI compute power and models. The move would pit it against the big cloud providers like Amazon Web Services, Google Cloud, and Microsoft Azure. 

Meta’s decision to sell off excess compute comes weeks after SpaceX, via xAI, announced similar plans. In early May, SpaceX signed a deal with Anthropic to buy out all of the compute capacity at SpaceX’s Colossus 1 data center. SpaceX has signed similar leases since with Google and Reflection AI. The fact that Meta is doing the same is a signal that the winners of the AI race may not be the ones providing the best models and services, but rather the ones who own the data centers.

That is, if the demand for compute continues to hold, and if data centers retain their value. Some skeptics have warned the race to build out AI infrastructure is creating a bubble that leans heavily on rapidly depreciating chips. Others have questioned whether AI companies can generate enough end-user revenue to justify the trillion-dollar bets. 

Those concerns haven’t stopped Meta from investing heavily in infrastructure for AI compute. As of the end of the first quarter, Meta had committed to spending $182.9 billion on AI infrastructure in the coming years, including massive ongoing projects in Louisiana and Ohio. The Ohio project, which Zuckerberg said would be the size of Manhattan, is expected to come online this year.

Unlike Google and OpenAI, Meta hasn’t seen significant demand for its own AI models and services. Meta doesn’t break out its revenue from Meta AI or from Llama, its open-weight AI model family, in its earnings, and executives have mostly emphasized the internal corporate uses of AI in public statements. That could mean that Meta’s AI endeavors don’t yet represent a material standalone revenue line. 

To get a return on some of its own colossal spend, Meta may copy CoreWeave’s business model and sell access to “raw” compute capacity, according to Bloomberg. The outlet also reported Meta is considering following AWS’s lead and selling access to various AI models — including its recently launched closed-weight model, Muse Spark — hosted on its AI infrastructure.

The new business line will be part of a new initiative reportedly dubbed Meta Compute, which is led by head of infrastructure Santosh Janardhan, Meta Superintelligence Labs leader Daniel Gross, and president Dina Powell McCormick.

The report confirms Zuckerberg’s May statements that a Meta cloud computing business is “definitely on the table” as a way to get a return on some of the massive investment into its strategy to develop AI “superintelligence.”

TechCrunch has reached out to Meta for comment.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Rebecca Bellan is a senior reporter at TechCrunch where she covers the business, policy, and emerging trends shaping artificial intelligence. Her work has also appeared in Forbes, Bloomberg, The Atlantic, The Daily Beast, and other publications.

You can contact or verify outreach from Rebecca by emailing [email protected] or via encrypted message at rebeccabellan.491 on Signal.

© 2023 Getty Images / Getty Images News via Getty Images

Shares of Tesla (NASDAQ:TSLA | TSLA Price Prediction) have been picking up in recent sessions, now close to 13% in just three sessions. Undoubtedly, just because Space Exploration Technologies (NASDAQ:SPCX) is the new hot Elon Musk stock in town does not mean shares of the EV juggernaut are going to be stuck going sideways for a while longer.

With the ambitious Terafab, a foundry, and some very impressive next-generation AI chips on the horizon, questions linger as to whether Tesla shares can outrun SpaceX. Certainly, SpaceX had its IPO at a fairly hefty price, and the price of admission has only grown since.

In any case, Tesla’s transition from EV maker to robotics innovator and AI chip play is already well underway. And arguably, the company has already delivered some pretty impressive innovations early on in its shifting of the gears.

The AI5 chip is jaw-droppingly impressive With the AI5 chip coming later in the year and the AI6 chip to follow, perhaps Tesla is the ultimate physical AI play and a more exciting bet than SpaceX, as Elon Musk looks to reduce its dependence on others as structural forces continue to make it tougher to get a spot on the production line. Given that AI demand could keep going from here, perhaps going down the route of a fab is the most logical thing to do, despite the price of the undertaking, the time it’ll take, and the very limited room for error.

In terms of breakthrough, the AI5 chip built on the 3nm process looks seriously impressive as the AI world moves into an inference inflection point. With reports of a 40x performance boost, it certainly feels like Tesla is the Magnificent Seven member with some of the most mouth-watering benchmarks.

Of course, it’s still early, but if the architecture behind the AI5 chip delivers, it’s not all too far-fetched to envision Tesla’s custom silicon stepping up to the plate as a serious challenger to Nvidia‘s (NASDAQ:NVDA) dominance. Of course, Nvidia’s not ignoring the opportunity at the edge either. Its RTX Spark superchip is every bit as impressive.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Tesla didn't make the cut. Grab the names FREE today.

However, at the end of the day, Tesla’s chips are all about efficiency rather than raw power.

When it comes to the edge, perhaps surgical precision beats brute force. And with an army of Optimus humanoid robots on the way, as well as Tesla’s robotaxi opportunity, Tesla’s custom silicon is already going to find a home in some seriously impressive embodied AI products. Any way you look at it, it looks like Tesla is about to become a disruptor again as it beckons in the age of robotics.

The road ahead looks bright for Tesla as several catalysts align With a massive data moat and a recent “40x performance boost” milestone in the books, it feels like Tesla might be the underestimated AI chip play that might just pull to the very front of the pack in this AI race. And with the 2nm AI6 chip to follow, count me as unsurprised if Tesla finds a way to silence the doubters as it finds huge success driving right into the age of robotics.

Full Self-Driving (FSD) v14 Lite has been released for Hardware 3 vehicles, And it finally feels like Tesla is finally delivering on its wild promises. The big question for investors moving forward is whether Optimus, Terafab, and the custom silicon roadmap will also be a success, even when the odds of failure are so high. It’s tough to say, but if you’re a Musk believer, I do think Tesla now looks a whole lot more interesting after its latest sudden surge.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Tesla didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

The RulingStockholm’s Patent and Market Court ruled in PriceRunner’s favor, awarding $1.97 billion in damages. The award compensates for lost revenue caused by Google’s preferential treatment of its own comparison-shopping service over independent price-comparison services—conduct the court found also drove up costs for consumers.

“When markets work well, everyone benefits. Consumers get higher quality at lower cost, companies stay focused on serving customers rather than defending position, and society is better off for it,” said Dan Greaves, Head of Communications and Policy at Klarna. “This ruling supports a healthier, more competitive market for the way people compare products and services.”

What Is PriceRunner?Klarna Shares Shoot HigherKLAR Price Action: At the time of publication, Klarna shares are trading 6.27% higher at $21.50, according to data from Benzinga Pro.

Image via Shutterstock

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

A Swedish court ruled that the search giant favored its own price-comparison service over Klarna's.